billHR8442Event Wednesday, April 22, 2026Analyzed

To amend title XXVII of the Public Health Service Act to establish civil liability for health insurance issuers with high levels of claims denials.

Neutral

Summary

HR8442 (Patient Refunds for Bad Denials Act) is an early-stage bill with one sponsor and one cosponsor, referred to committee on April 22, 2026. It proposes civil penalties for health insurers with claims denial rates at or above 25%, but faces a long legislative path. Major health insurers ($HUM, $CI, $CVS) have rallied 9-38% over 30 days, and this bill presents no immediate stock-moving catalyst given its procedural stage.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR8442 is a procedural early-stage bill with no near-term market impact.
  • 2.The bill authorizes no spending—it creates a penalty framework with no funding mechanism.
  • 3.Real market data shows health insurers rallying significantly post-introduction, indicating the market is not pricing in this risk.
  • 4.Legislative path requires passage through both chambers and presidential signature—unlikely in current form given limited support.

Market Implications

No immediate market implications given the bill's procedural stage. The 9-38% rally in major health insurers over the past 30 days reflects sector fundamentals, not legislative overhang. $HUM at $238.85, $CI at $291.50, and $CVS at $83.11 all trade near their recent highs, with no selling pressure observed around the April 22 introduction date. Investors should monitor committee scheduling for any markup activity, which would be the first meaningful signal of legislative momentum.

Full Analysis

HR8442 was introduced on April 22, 2026 by Rep. Craig (D-MN) and referred to the House Committee on Energy and Commerce. The bill, with only one cosponsor and no further action history, is at the earliest legislative stage. It proposes a civil monetary penalty framework for health insurance issuers whose claims denial percentage reaches 25% or greater, with enforcement via HHS audits. However, this bill does not authorize or appropriate any funding—it creates a regulatory penalty structure. Actual market impact requires the bill to advance through subcommittee markup, full committee, House floor, Senate, and presidential action—a multi-year process with high attrition probability. Real market data shows $HUM up 37.75% over 30 days, $CI up 9.28%, and $CVS up 15.72%. These rallies are driven by factors unrelated to this bill (e.g., earnings, broader sector rotation), not legislative risk. $HUM's close on the bill's introduction date was $217.40, and it rose 9.9% over the following week to $238.85—directly contradicting any negative market reaction to the news.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →